A comparative study of ceftazidime/avibactam-based and fosfomycin plus meropenem-based regimens for managing infections caused by carbapenem-resistant <i>Klebsiella pneumoniae</i> in critically ill patients-Reference-Cited by-同舟云学术

A comparative study of ceftazidime/avibactam-based and fosfomycin plus meropenem-based regimens for managing infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients

Published:2024-05-03 Issue: Volume: Page:1-9
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Önal Uğur¹^ORCID,Tüzemen Ülkü²,Küçükdemirci Kaya Pınar³,İşçimen Remzi³,Kelebek Girgin Nermin³,Özakın Cüneyt²,Kahveci Ferda³,Akalın Halis¹

Affiliation:

1. Department of Infectious Diseases and Clinical Microbiology, Uludag University, Bursa, Türkiye

2. Department of Medical Microbiology, Uludag University, Bursa, Türkiye

3. Department of Anesthesiology and Reanimation, Uludag University, Bursa, Türkiye

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2024.2349439

Reference28 articles.

1. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

2. Antimicrobial resistance surveillance in Europe 2023 - 2021 data. Stockholm: European Centre for Disease Prevention and Control and World Health Organization [Internet]. [cited 2023 Sep 10]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Antimicrobial%20resistance%20surveillance%20in%20Europe%202023%20-%202021%20data.pdf

3. Republic of Türkiye Ministry of Health General Directorate of Public Health Department of Infectious Diseases and Early Warning. Healthcare associated infections surveillance network (USHİESA) summary report 2022 [Internet]. [cited 2023 Sep 10]. Available from: https://hsgmdestek.saglik.gov.tr/depo/birimler/Bulasici-hastaliklar-db/hastaliklar/SHIE/Raporlar/USHIESA_OZET_RAPORU_2022.pdf

4. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

5. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic antibacterial activity of ceftazidime–avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae;Scientific Reports;2024-07-30